CX Daily: China Formally Enlists ‘Miracle’ Drug in Fight Against Ballooning Obesity Rate
Listen to the full version

Drugs /
Cover Story: China formally enlists ‘miracle’ drug in fight against ballooning obesity rate
Fang Xia, a 24-year-old woman, has faced a lifelong struggle with obesity, a condition that has plagued her both physically and psychologically. But like millions of others around the world, her life was turned around after taking semaglutide, a glucagon-like peptide-1 (GLP-1) analog that mimics a hormone that triggers a sense of fullness and helps overweight people shed the pounds.

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR